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OBJECTIVES Evaluation of collateral vascular circulation according to hemodynamic variables and its
relation to myocardial ischemia.
BACKGROUND There is limited information regarding the hemodynamic quantification of recruitable
collateral vessels.
METHODS Angiography of the donor coronary artery was performed before and during balloon coronary
occlusion in 63 patients with one vessel disease. Patients were divided into groups of those
with an absence of collateral vessels (group 1, n 5 10), those with recruitable collateral vessels
(group 2, n 5 23) and those with spontaneously visible collateral vessels (group 3, n 5 30).
During balloon inflation the coronary wedge/aortic pressure ratio (Pw/Pao) was determined
as were collateral blood flow velocity variables, using a 0.0140 Doppler guide wire. Myocardial
ischemia was defined as $0.1 mV ST-shift on a 12 lead electrocardiogram at 1 min coronary
occlusion.
RESULTS Myocardial ischemia was present in all patients of group 1, in 14 patients of group 2 and in
3 patients of group 3. Recruitable collateral flow without ischemia showed similar hemody-
namic values as in group 3 while these values were similar to group 1 in regard to the presence
of recruitable collateral vessels showing ischemia. Logistic regression analysis revealed both
Pw/Pao and Vicol as independent predictors for the function of collateral vessels.
CONCLUSIONS Hemodynamic variables of collateral vascular circulation are better markers of the functional
significance of collateral vessels than is coronary angiography. The total collateral blood flow
velocity integral and coronary wedge/aortic pressure ratio are good and independent
predictors of the function of collateral vessels producing complementary information. (J Am
Coll Cardiol 1999;33:670–7) © 1999 by the American College of Cardiology
Numerous reports have underlined the functional signifi-
cance of the coronary collateral circulation in obstructive
coronary artery disease (1–8). Several studies have reported
the evaluation of the coronary collateral circulation using
hemodynamic variables (pressure or blood flow velocity)
(9–19). However, only a limited number of studies have
been performed using both pressure and flow-derived vari-
ables which are of crucial importance for the evaluation of
the collateral vascular circulation (20,21). Coronary balloon
occlusion is a suitable model to study the hemodynamics of
collateral vessels in humans in relation to its protective
function.
Initial reports evaluated hemodynamic estimates of the
collateral vascular circulation in relation to the angiographic
grading of collateral vessels according to Rentrop’s classifi-
cation before balloon coronary occlusion. However, several
studies emphasized the relevance of angiography during
balloon coronary occlusion using an additional arterial
catheter for documentation of recruitable collateral vessels
(10,17,20). Consequently, the purpose of this study was to
evaluate the relationship between angiographic presence of
collateral vessels, including recruitability of collaterals, dur-
ing coronary occlusion and hemodynamic variables of the
collateral vascular circulation. The variables were related to
the function of collateral vessels determined by signs of
ischemia during brief coronary occlusion. Furthermore,
these findings were compared to the variables obtained in
patients with spontaneously visible collateral vessels in
subtotal or total coronary occlusions.
METHODS
Sixty-three patients (mean age 55 6 10, range 33–75 years)
with one-vessel coronary artery disease, referred to our
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institution for PTCA, were studied prospectively. Inclusion
criteria were: 1) angina pectoris refractory to medical ther-
apy, and 2) coronary narrowing or total coronary occlusion
suitable for balloon angioplasty. Exclusion criteria were: 1)
multilesion one-vessel disease, 2) previous cardiac surgery,
3) peripheral artery disease limiting arterial access. A total of
27 (43%) of the 63 patients underwent cardiac catheteriza-
tion due to postinfarct angina, 6 patients experienced a
Q-wave infarction. Informed consent was given in accor-
dance with the rules of the Institutional Ethics Committee
which approved the study.
Cardiac catheterization. All antianginal medications and
aspirin (100 mg) were continued until cardiac catheteriza-
tion. Lorazepam (1 mg) was administered orally before the
procedure. Nitroglycerin (0.1 mg i.c.) was administered
before quantitative coronary angiography and repeated only
in case of the occurrence of coronary spasm. Cardiac
catheterization was performed using the percutaneous fem-
oral approach. A 6 or 7 Fr sheath was inserted into both the
right and left femoral arteries. One guiding catheter was
used for introduction of a Doppler guide wire and the
balloon catheter in the recipient coronary artery and one
additional guiding catheter was used for angiography of the
donor coronary artery. At the beginning of the catheteriza-
tion, all patients received heparin intravenously (5000 U) as
a bolus. Additional heparin was administered if the proce-
dure lasted more than 90 minutes.
The angiographical grading of collateral vessels was
determined before and during the first balloon inflation.
During the subsequent balloon inflations, collateral flow
velocity was obtained. Subsequently, the Flowire was re-
moved and coronary wedge pressure was measured through
a fluid-filled lumen during at least two additional balloon
inflations.
Quantitative coronary angiography. Angiography of the
donor artery was performed before angioplasty by automatic
contrast injection (Angiomat 3000, Liebel-Flarsheim Co.,
Cincinnati, Ohio; right coronary artery 4 to 6 ml, 7 ml/s;
left coronary artery 6 to 8 ml, 9 ml/s). Cineangiography was
continued until there was no further opacification of the
injected vascular bed. A repeat arteriogram of the donor
artery was obtained at 30 seconds during the first balloon
inflation. The severity of the coronary narrowing was
determined by an automated contour detection algorithm
(ARTREK, ADAC Laboratories, Evendale, California) in
two orthogonal projections, using the guiding catheter as a
reference, to obtain the percentage diameter stenosis and
the minimal lumen diameter.
Collateral vessels were graded according to Rentrop’s
classification (22); 0 5 no filling of collateral vessels; 1 5
filling of collateral vessels without any epicardial filling of
the artery to be dilated; 2 5 partial epicardial filling by
collateral vessels of the artery to be dilated; and 3 5
complete epicardial filling by collateral vessels of the artery
to be dilated. The grading of the collateral vessels was
performed independently by 2 angiographers and a consen-
sus was reached in the case of disagreement (k 5 0.85, CI
0.77–0.93). Collateral vessels were considered recruitable
when they were absent before coronary occlusion (grade 0 or
1) and present during coronary occlusion (grade 2 or 3, k 5
0.94, CI 0.88–1.00). Collateral vessels were classified spon-
taneously visible when they were grade 2 or 3 before
coronary occlusion. Electrocardiographic signs of ischemia
during coronary occlusion of one minute duration were
evaluated by the maximal ST-segment changes in a 12-lead
electrocardiogram. Ischemia was defined as $1 mV ST-
segment shift in at least one lead. Heart rate obtained from
the electrocardiogram was monitored throughout the pro-
cedure.
Collateral flow velocity. A 0.0140 Doppler guide wire,
equipped with a forward-directed piezoelectric Doppler
crystal at its tip (FloWire, EndoSonics, Rancho Cordova,
California) was inserted in the recipient coronary artery in
order to accurately assess collateral blood flow velocity distal
to the balloon occlusion (23). The Doppler signals of the
FloWire were generated by 12-MHz pulsed Doppler velo-
cimeter and were processed by a real-time spectral analyzer
using fast Fourier transformation (FloMap, EndoSonics,
Rancho Cordova, California). Coronary blood flow velocity
in the recipient artery was assessed during the first and
subsequent balloon inflations of approximately one minute
duration. Collateral flow was considered present in the case
of a blood flow velocity signal with a diastolic maximal peak
velocity exceeding 5 cm/s. Collateral flow in the recipient
coronary artery during balloon inflation was determined by
the total (Vicol), systolic (sVicol) and diastolic collateral
blood flow velocity integral (dVicol) and the diastolic max-
imal peak velocity (dMPVcol). In biphasic collateral blood
flow velocity signals, Vicol was calculated as the sum of the
absolute values of sVicol and dVicol. These collateral blood
flow velocity variables were assessed off-line by manual
tracing of the peak blood flow velocity pattern from a
digitized video-frame, averaged over three consecutive
beats, using a software program available on the Internet
(NIH Images 1.58, National Institutes of Health, Bethesda,
Maryland).
Abbreviations and Acronyms
Rcoll 5 collateral vascular resistance
Pw 5 coronary occlusion wedge pressure
Pw/Pao 5 coronary wedge/aortic pressure ratio
dVicol 5 diastolic collateral blood flow velocity integral
Rrec 5 peripheral vascular resistance of the recipient
coronary artery
ROC 5 receiver operating characteristics
sVicol 5 systolic collateral blood flow velocity integral
Vicol 5 total collateral blood flow velocity integral
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Pressure measurements and collateral resistance. Mean
aortic pressure (Pao) was measured at the tip of the guiding
catheter. The mean coronary occlusion wedge pressure (Pw)
was measured at the tip of the balloon catheter through the
fluid-filled lumen during balloon inflation. Both measure-
ments were assessed simultaneously during balloon coronary
occlusion to determine the Pw/Pao ratio. The collateral
vascular resistance (Rcoll) was assessed by relating Vicol to
the pressure gradient (Pao 2 Pw) upon the collateral
vascular bed using the assumption that the resistance of the
epicardial donor coronary artery is negligible: Rcoll (mm
Hg/cm) 5 (Pao 2 Pw)/Vicol. The myocardial vascular
resistance of the recipient coronary artery (Rrec) was calcu-
lated as: Rrec 5 Pw/Vicol (21).
Statistics. Continuous variables are expressed as means 6
1 SD. The two sample t test was used to compare contin-
uous variables of patients with and without signs of myo-
cardial ischemia. Continuous data without a normal distri-
bution or without similar variances were compared using the
Mann-Whitney U test. Analysis of variance (ANOVA) for
ordered groups (considering a significant linear trend) was
used to compare continuous data between the ordered
patient groups classified as having no collateral vessels, those
with recruitable collateral vessels and those with spontane-
ously visible collateral vessels. Frequency data are presented
together with summaries as rounded percentages. The
Chi-squared test was used for comparing two proportions
and the Chi-squared test for trend was used to compare
frequency data of the ordered patient groups. The predictive
values of the pressure and collateral blood flow velocity
variables in relation to ECG signs of ischemia were evalu-
ated using their respective areas under the receiver operating
characteristics (ROC) curves. The best cut-off value for each
variable of interest was determined by the value representing
the largest area (sensitivity 3 specificity) of the specific
ROC curve. Logistic stepwise regression analysis was per-
formed to determine independent explanatory variables of
functional recruitable collateral vessels. For this reason,
continuous pressure and collateral blood flow velocity vari-
ables were transformed into binominal values according
their best cut-off value. A p value ,0.05 was considered
statistically significant.
RESULTS
Angiographic and functional classification of collateral
vessels. Angiographic opacification of the collateral vessels
before balloon angioplasty was graded 0 in 23 patients,
graded 1 in 10 patients, graded 2 in 13 patients and graded
3 in 17 patients. During balloon coronary occlusion, 2
patients were graded 0, 8 patients were graded 1, 25 patients
were graded 2 and 28 patients were graded 3, resulting in:
10 patients with an absence of collateral vessels (Group 1),
23 patients with recruitable collateral vessels (Group 2) and
30 patients with spontaneously visible collateral vessels
(Group 3). Baseline characteristics of these 3 groups are
listed in Table 1.
Electrocardiographic signs of ischemia during balloon
coronary occlusion were present in 26 of the 63 patients.
Ischemia was present in all the patients without collateral
vessels, in 14 of the 23 patients (61%) with recruitable
collateral vessels and in only 3 of the 30 patients (10%) with
spontaneously visible collateral vessels.
Hemodynamic variables of the collateral vascular circu-
lation in relation to myocardial ischemia. Pressure mea-
surements were successful in all patients. Of all the collateral
blood flow velocity and pressure variables, only Vicol, dVicol,
Pw and Pw/Pao revealed higher values in patients with
spontaneously visible collateral vessels and lower values in
patients without collateral vessels during balloon coronary
occlusion as compared to the values measured in recruitable
collateral vessels (Table 2). Of these variables, only Vicol, Pw
and Pw/Pao were useful in differentiating between func-
tional and nonfunctional recruitable collateral vessels (Table
2). The values of Vicol, Pw and Pw/Pao measured in
nonfunctional recruitable collateral vessels were similar to
the values measured in patients without collateral vessels
during balloon occlusion while values measured in func-
tional recruitable collateral vessels were equal to values
measured in spontaneously visible collateral vessels (Table
2).
Direct comparison of blood flow velocity and pressure
measurements in predicting the functionality of collat-
eral vessels. The ROC curves of the collateral blood flow
velocity variables (Vicol, dVicol, sVicol and dMPVcol) and the
pressure variables (Pw and Pw/Pao) for the presence of
ischemia are depicted in Figure 1. The Vicol generated the
largest area under the ROC curve (Table 3). However, the
area under the curve of Vicol was not significantly different
from the areas under the ROC curves of dVicol and Pw/Pao
and Pw. The area under the ROC curve of sVicol was
significantly smaller as compared with the other variables
(Table 3).
Although there was no relevant difference between the
areas under the curves of Vicol and Pw/Pao (Table 3), their
relationship was modest (r 5 0.61, p , 0.0001, Fig. 2).
Logistic regression analysis for the presence of ischemia
during balloon occlusion was performed to test whether
these two variables were independent. To this end, all blood
flow velocity and pressure variables were transformed into
binominal variables using their best cut-off values (Table 3).
The Vicol and Pw/Pao were the only independent predictors
of ischemia after stepwise logistic regression analysis. The
regression equation for the model using these variables is:
logit (p) 5 22.21 1 2.89 (Pw/Pao #0.30) 1 2.54 (Vicol
#6.0), p , 0.0001. The overall accuracy of this regression
equation was 0.84 (Fig 2).
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DISCUSSION
This is the first study evaluating the functional significance
of coronary collateral vessels in relation to pressure and
flow-derived variables in a relatively large cohort of patients.
The results show a gradual increase in hemodynamic esti-
mates of the collateral vascular circulation in patients
without collateral vessels to patients with maximal develop-
ment of collateral vessels in subtotal or total coronary
occlusions. The assessed hemodynamic variables are better
markers for the evaluation of functional significance of
recruitable collateral vessels than is coronary angiography.
Furthermore, Vicol and Pw/Pao are independent predictors
for development of myocardial ischemia during brief coro-
nary occlusion emphasizing that the assessment of both
variables provides complementary information.
Coronary angiography and hemodynamic variables for
evaluation of the collateral vascular circulation in hu-
mans. Previous clinical studies. Many clinical investigations
have demonstrated a positive relationship between the
angiographic classification of collateral vessels assessed be-
fore balloon occlusion and the occurrence of ischemia or
ventricular wall motion disturbances during subsequent
coronary balloon occlusions (10,13,14). However, the ma-
jority of these studies did not include an assessment of
recruitable collateral vessels. Subsequent reports demon-
strated that the grading of collateral vessels during balloon
angioplasty was significantly correlated with ST-segment
shifts and the extent of wall motion disturbances during
brief coronary occlusion, emphasizing the relevance of
documentation of recruitable collateral vessels (10,15). Re-
cruitability of collateral vessels was associated with hemo-
dynamic estimates of the collateral vascular circulation
yielding a higher value of Pw (12), Pw/Pao (20) or collateral
blood flow velocity measured in the ipsilateral (20) and/or
contralateral coronary artery (17,20) as compared with those
patients without collateral vessels during balloon occlusion.
However, preliminary findings by Meier et al. (12) demon-
strated that not all patients with recruitable collateral vessels
were protected from ischemia during brief balloon occlu-
sion, suggesting that coronary angiography may be inade-
quate to assess the functional significance of recruitable
collateral vessels. A direct comparison between the angio-
graphic and the hemodynamic variables of recruitable col-
lateral vessels in the development of myocardial ischemia
during balloon occlusion was not performed in these studies.
Table 1. Baseline and Angiographic Characteristics of Patients Without Collateral Vessels
(Group 1), Recruitable Collateral Vessels (Group 2) and Spontaneously Visible Collateral Vessels
(Group 3)
Characteristic
Group 1
n 5 10
Group 2
n 5 23
Group 3
n 5 30 p-value
Age (yr) 59 6 11 53 6 9 56 6 10 0.27
Male 6 (60%) 19 (83%) 19 (63%) 0.24
AP (NYHA):
2 2 (20%) 2 (9%) 5 (17%) 0.54
3 5 (50%) 13 (57%) 21 (70%)
4 3 (30%) 7 (30%) 3 (10%)
Duration of AP (mos) 4.8 6 3.2 6.9 6 9.8 7.4 6 7.9 0.47
Smoking 5 (50%) 10 (43%) 14 (47%) 0.94
Hypertension 2 (20%) 6 (26%) 9 (30%) 0.82
Hypercholesterolemia 5 (50%) 17 (74%) 20 (67%) 0.41
Diabetes mellitus 0 (0%) 1 (4%) 2 (7%) 0.69
Previous myocardial infarction 1 (10%) 7 (30%) 19 (63%) 0.004
Medication:
Nitrates 5 (50%) 13 (57%) 23 (77%) 0.17
Beta-blocker 8 (80%) 23 (100%) 25 (83%) 0.10
Calcium-antagonist 8 (80%) 18 (78%) 24 (80%) 0.99
Treated coronary artery:
LAD 9 (90%) 17 (74%) 17 (57%) 0.17
LCx 0 (0%) 2 (9%) 1 (3%)
RCA 1 (10%) 4 (17%) 12 (40%)
Proximal lesion location 4 (40%) 6 (26%) 14 (47%) 0.31
TIMI flow:
0 0 (0%) 0 (0%) 17 (57%) , 0.0001
1 0 (0%) 0 (0%) 10 (33%)
2 0 (0%) 5 (22%) 2 (7%)
3 10 (100%) 18 (78%) 1 (3%)
% Diameter stenosis 70 6 7 81 6 10 96 6 11 , 0.0001
AP 5 angina pectoris; LAD 5 left anterior descending coronary artery; LCx 5 left circumflex coronary artery; NYHA 5 New
York Heart Association; RCA 5 right coronary artery; TIMI 5 thrombolysis in myocardial infarction.
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Results of the present study. The present study shows that
the number of patients developing signs of myocardial
ischemia during brief coronary occlusion is reduced in those
patients with recruitable or spontaneously visible collateral
vessels which is in accordance with the aforementioned
clinical studies. However, a variable protective effect was
noted in patients with recruitable collateral vessels which is
in keeping with the observations by Meier et al. (12).
Patients with and without electrocardiographic signs of
myocardial ischemia could be differentiated according to the
hemodynamic variables of the collateral vascular circulation
(Pw, Pw/Pao and Vicol) indicating that these variables are
better markers of the protective effect of recruitable collat-
eral vessels. Moreover, the hemodynamic variables mea-
sured in patients with recruitable collateral vessels showing
absence of myocardial ischemia were similar to the values
obtained in patients with spontaneously visible collateral
vessels while these variables measured in patients with
recruitable collateral vessels with ischemia were similar to
the values obtained in patients without collateral vessels
during balloon angioplasty. This indicates that the gradual
increase in the mean value of Pw/Pao and Vicol from
patients without collateral vessels to patients with sponta-
neously visible collateral vessels is in fact a rather abrupt
transition with respect to the functional significance of
collateral vessels. These findings emphasize the limitations
of angiographical grading of collateral vessels to evaluate the
protective effect of recruitable collateral vessels in an indi-
vidual patient and underscores the value of hemodynamic
variables of the collateral vascular circulation.
Figure 1. Receiver operating characteristic curves for the presence
of ischemia of the hemodynamic variables measured. dMPVcol 5
diastolic collateral maximal peak velocity; dVicol 5 diastolic
collateral blood flow velocity integral; Pw 5 mean coronary wedge
pressure; Pw/Pao 5 coronary wedge/aortic pressure ratio; Rcoll 5
collateral resistance; Rrec 5 peripheral resistance of the recipient
coronary artery; sVicol 5 systolic collateral blood flow velocity
integral; Vicol 5 total collateral blood flow velocity integral.
Table 2. Hemodynamic Values Measured in the Patient Group Without Collateral Vessels (Group 1), Recruitable Collateral Vessels
(Group 2) and Spontaneously Visible Collateral Vessels (Group 3) in Patients With and Without Ischemia During
Balloon Angioplasty
Group 1 Group 2 Group 3
Ischemia
(n 5 10)
No
Ischemia
(n 5 0)
Ischemia
(n 5 14)
No
Ischemia
(n 5 9)
All
(n 5 23)
Ischemia
(n 5 3)
No
Ischemia
(n 5 27)
All
(n 5 30)
Heart rate (beats/min) 65 6 15 — 68 6 10 64 6 11 66 6 10 91 6 12† 64 6 10* 66 6 13
Pao (mm Hg) 96 6 13 — 97 6 11 88 6 10 93 6 11 99 6 3 100 6 12† 100 6 11
Pw (mm Hg) 22 6 8 — 27 6 8 36 6 11* 30 6 10 47 6 82† 45 6 13 45 6 13†
Pw/Pao 0.24 6 0.08 — 0.28 6 0.08 0.41 6 0.13* 0.33 6 0.12 0.47 6 0.09† 0.45 6 0.11 0.45 6 0.11†
dMPVcol (cm/s) 3.6 6 4.8 — 10.1 6 9.2† 15.6 6 9.4 12.3 6 9.5 16.0 6 8.2† 17.4 6 9.1 17.3 6 8.9†
dVicol (cm) 0.6 6 0.8 — 2.2 6 2.3† 3.9 6 2.9 2.9 6 2.7 4.1 6 4† 7.0 6 4.0† 6.7 6 4.0†
sVicol (cm) 1.9 6 2.2 — 2.2 6 2.1 6.7 6 3.8* 3.9 6 3.6 2.5 6 0.5 3.1 6 1.9† 3.1 6 1.8
Vicol (cm) 2.5 6 2.0 — 4.4 6 3.2 10.6 6 5.2* 6.8 6 5.0 6.7 6 3.9 10.2 6 4.9 9.8 6 4.9†
Rcoll (mm Hg/cm) 44.0 6 34.9 — 33.4 6 36.7 5.8 6 2.7* 22.6 6 31.4 10.6 6 7.6 6.5 6 3.1 6.9 6 3.8†
Rrec (mm Hg/cm) 9.5 6 5.3 — 5.7 6 2.7 3.7 6 1.3 4.8 6 5.7 8.2 6 3.2 5.2 6 2.6 5.5 6 7.5†
* p , 0.05, compared to patients with ischemia in the same group; † p , 0.05; ANOVA for ordered patient groups. dMPVcol 5 diastolic collateral maximal peak velocity;
dVicol 5 diastolic collateral blood flow velocity integral; Pao 5 mean aortic pressure; Pw 5 mean coronary wedge pressure; Rcoll 5 collateral resistance, Rrec 5 peripheral
resistance of the recipient coronary artery; sVicol 5 systolic collateral blood flow velocity integral; Vicol 5 total collateral blood flow velocity integral.
Table 3. Receiver Operating Characteristic Curves of
Angiographical and Hemodynamic Variables in Relation to the
Absence and Presence of Ischemia
AUC BCV
Sensitivity
(%)
Specificity
(%)
Vicol (cm) 0.89 6 0.04 6.0 78 89
dVicol (cm) 0.87 6 0.05 2.8 78 86
Pw/Pao 0.85 6 0.05 0.30 70 94
Pw (mm Hg) 0.82 6 0.05 35 78 69
dMPVcol (cm/s) 0.77 6 0.06 10 67 83
sVicol (cm) 0.71 6 0.07* 2.5 70 64
* p , 0.05 as compared with all other variables. AUC 5 area under the curve; BCV 5
best cut-off value; other abbreviations as in Table 2.
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Hemodynamic evaluation of the collateral vascular cir-
culation. Logistic regression analysis revealed Pw/Pao and
Vicol as independent predictors of the protective effect of
collateral vessels. Both hemodynamic variables are required
to calculate the collateral vascular resistance and peripheral
myocardial vascular resistance of the recipient coronary
artery. Experimental work of Schaper et al. (24) using
canine subjects showed the relevance of measuring both
variables as a decrease in collateral resistance during chronic
coronary occlusion of 18 weeks resulted in an increase in
collateral blood flow while the coronary wedge pressure
remained unchanged. This observation is explained by a
concomitant decrease in both the collateral vascular resis-
tance (resulting in an increase of collateral flow and Pw/Pao)
and the peripheral vascular resistance of the recipient
coronary artery (resulting in an increase in collateral flow
and a decrease in Pw/Pao). These experimental findings
were confirmed in a recent clinical study evaluating the
pharmacological modulation of collateral vascular resistance
by vasodilators (21). These studies emphasize the need for
measuring both pressure and flow-derived variables of the
collateral vascular circulation providing insight into the
dynamics of the coronary collateral circulation in humans.
Study limitations. The accuracy of blood flow velocity
analysis in the recipient coronary artery for the assessment of
collateral flow has not been validated against a “gold
standard” for myocardial perfusion in humans. Positron
emission tomography has been applied to assess myocardial
perfusion in collateral-dependent vascular areas in chronic
coronary occlusion (25,26). However, this technique pre-
cludes the assessment of recruitable collateral flow.
This study was performed in a selected group of patients
with one-vessel disease. The medical therapy of the patients
studied was not uniform and this may have contributed to
the variations observed among the patients. The angio-
graphic grading of collateral vessels is sensitive to variations
in the technique applied and is subject to intra- and
interobserver variability. Moreover, intracoronary blood
flow velocity assessment is a sensitive technique for the
detection of alterations in blood flow, but this method for
the assessment of collateral flow is prone to technical failures
due to the position of the guide wire tip relative to the input
of collateral flow and the induction of artifacts by contact
with vessel wall and excessive guide wire motion within the
target vessel.
Furthermore, the potential decrease of the caliber of the
artery distal to the balloon during balloon occlusion may
result in an overestimation of collateral blood flow in
patients with low blood flow velocity signals and a low mean
coronary wedge pressure. Therefore, it is possible that the
differences observed in collateral blood flow velocity be-
tween patients with and without recruitable collateral vessels
are an underestimation of the true differences in collateral
volume flow due to this phenomenon.
The functional significance of collateral vessels during
coronary occlusion was judged by electrocardiographic
monitoring only during brief coronary occlusion and the
method was not expanded to include hemodynamic moni-
toring or assessment of global or regional ejection fractions.
The development of electrocardiographic signs of ischemia
during coronary occlusion may be influenced by the rela-
tionship between the size of the myocardium “at risk” and
extent of the collateral-dependent vascular bed which were
not assessed in the present study. Finally, the limited
number of studies performed regarding the coronary collat-
eral circulation evaluated in an angioplasty model requires
confirmation of these findings by other investigators.
Clinical implications. The present study documents the
maximal collateral vascular circulation in obstructive coro-
nary artery disease represented by a Pw/Pao of ;0.45 and a
Vicol of ;10 cm in patients with recruitable or spontane-
ously visible collateral vessels. Obviously, this extent of the
collateral vascular circulation is inadequate for myocardial
perfusion in order to relieve patients from stress-induced
symptoms. Nevertheless, it is possible that symptomatic
patients are a selection of patients with inadequate adapta-
tion of the coronary collateral circulation as compared with
asymptomatic patients with coronary artery disease. At
present the factors determining the maximal collateral
vascular circulation are the subject of experimental studies
that may lead to new treatment modalities in the near
future.
A limited number of studies concern the pharmacological
responsiveness of collateral vessels showing an increase of
flow to collateral-dependent myocardium by vasodilators
such as nitroglycerin and adenosine (21,27,28). Preliminary
Figure 2. Relationship between the mean coronary wedge pres-
sure/mean aortic pressure ratio (Pw/Pao) and the total collateral
blood flow velocity integral (Vicol) in patients split by the presence
of ischemia and angiographical grading of collateral vessels (group
1–3).
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data suggest that the pharmacological modulation of collat-
eral resistance is more pronounced in patients with sponta-
neously visible collateral vessels as compared with patients
with recruitable collateral vessels (21). This phenomenon
may be related to the morphology of the collateral vascular
wall as suggested by experimental studies (29). Recent
clinical studies have indicated a response in the collateral
vascular growth in patients with peripheral artery disease
after treatment with growth factors or gene therapy (30,31).
Nevertheless, our current understanding regarding the pro-
cess of the collateral vascular circulation stimulation is
incomplete and the subject of intensive experimental re-
search. The present study emphasizes the relevance of using
hemodynamic variables for evaluation of the collateral
vascular circulation in humans.
However, the evaluation of new pharmacological agents
or gene therapy requires quantitative assessment of the
collateral vascular circulation providing insight into the
modulation of collateral flow indexes using noninvasive
techniques such as positron emission tomography or by
using hemodynamic variables in invasive techniques as
shown in the present study.
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